Sulfapyridine

Sulfapyridine

Cat. No.: PI144832

Product Details Other Identifiers
CAS 144-83-2
Synonyms 2-(4-Aminobenzenesulfonamido)pyridine
Molecular Formula C11H11N3O2S
Molecular Weight 249.29
End Use Sulfasalazine
Product Status Commercial
IUPAC Name 4-amino-N-pyridin-2-ylbenzenesulfonamide
InChI InChI=1S/C11H11N3O2S/c12-9-4-6-10(7-5-9)17(15,16)14-11-3-1-2-8-13-11/h1-8H,12H2,(H,13,14)
InChI Key GECHUMIMRBOMGK-UHFFFAOYSA-N
Canonical SMILES C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N
Case Study

Sulfapyridine: Advancing Therapeutics Through Self-Assembling Prodrugs for Rheumatoid Arthritis Management

Nanoscale self-assembling prodrugs of sulfapyridine for treatment of arthritis: Harnessing the dual approach Rani P, et al. Medical Hypotheses, 2022, 165, 110896.

Sulfapyridine, an active moiety derived from sulfasalazine, holds significant potential for the treatment of rheumatoid arthritis (RA). However, traditional formulations necessitate high doses (2-3 g/day), resulting in adverse effects including agranulocytosis, hematuria, and psychosis. Additionally, sulfapyridine's biphasic solubility in water (268 mg/L) and n-octanol (243.3 mg/L) presents significant formulation challenges.
Self-assembling prodrugs offer a promising alternative. These amphiphilic molecules spontaneously form nanostructures, creating a built-in delivery system. These structures improve pharmacokinetics by extending circulation time, reducing renal clearance, and increasing drug accumulation at target sites. The encapsulation also protects sulfapyridine from degradation, enhancing stability during storage and administration. In comparative studies, self-assembling prodrug systems demonstrated superior therapeutic profiles compared to liposomal formulations, which are often hindered by complex preparation, instability, and cost inefficiencies. Prodrugs designed with flexible polyunsaturated fatty acid chains exhibited enhanced assembly and improved therapeutic efficacy. Furthermore, dual drug-loaded self-assembling hydrogels enabled controlled release and synergistic therapeutic effects.

Sulfapyridines for the Preparation of Multifunctional Electrochemical Sensing Materials

A simple membrane with the electroactive [Sulfapyridine-H]+[Co(C2B9H11)2]- for the easy potentiometric detection of sulfonamides Saini A, et al. Journal of Organometallic Chemistry, 2019, 893, 32-38.

Sulfapyridines can be used to prepare multifunctional electrochemical sensing materials [sulfapyridine-H]+[Co(C2B9H11)2]-. The synthesis of [Sulfapyridine-H]+[Co(C2B9H11)2]-, a novel electroactive salt, demonstrates its applicability in potentiometric detection of sulfonamides.
The salt [Sulfapyridine-H]+[Co(C2B9H11)2]- was synthesized through a two-step process. Cs[3,3'-Co(1,2-closo-C2B9H11)2] was extracted using aqueous HCl and diethyl ether. After removing diethyl ether, the residue was diluted to a 0.05 M solution. Simultaneously, Sulfapyridine was dissolved in water with minimal HCl to prepare a 0.05 M acid solution. Mixing these solutions yielded a yellow precipitate, which was isolated and purified under vacuum.
The composition of the synthesized salt was confirmed by 1H NMR spectroscopy, where the integration of metallacarborane and Sulfapyridine proton signals revealed a stoichiometry consistent with a 1:1 salt. This indicates successful complex formation, crucial for its intended electrochemical applications.

Sulfapyridine for the Preparation of Safe Nano-formulations of Sulfapyridine Pre-drugs

Fail-safe nano-formulation of prodrug of sulfapyridine: Preparation and evaluation for treatment of rheumatoid arthritis Kapoor B, et al. Materials Science and Engineering: C, 2021, 118, 111332.

Sulfapyridine (SP) serves as a precursor in the synthesis of its amide prodrug (SP-PD). The synthesis of SP-PD began with the dissolution of Sulfapyridine in anhydrous dimethylformamide (DMF) under alkaline conditions facilitated by potassium carbonate. To this solution, decanoyl chloride was added dropwise, maintaining a controlled temperature of 15-20 °C to prevent side reactions. The reaction mixture was subsequently stirred for four hours at ambient temperature, followed by the addition of excess water to quench the reaction. Vacuum filtration was employed to isolate the crude product, which was extensively washed to remove residual DMF.
The crude SP-PD was purified using silica gel column chromatography with a hexane-ethyl acetate gradient elution system. Thin-layer chromatography (TLC) confirmed the reaction's progress and product identity, visualized under ultraviolet light. High-performance liquid chromatography (HPLC) with a reverse-phase C18 column validated the product's purity. Gradient elution with a mobile phase of water and acetonitrile, both containing 0.1% v/v formic acid, ensured precise quantification of purity.

* Our products are for research use only.

Get in Touch

We’re glad to help you with your products and services demands. For any inquiry, question or recommendation, please send an email to or fill out the following form.

Verification code
For product and service inquiries icon1

For product and service inquiries, please use our online system or send an email to .

For product and service inquiries icon2